The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Therapeutic Nuclear Medicines Revenue 1.5 Market Analysis by Type 1.5.1 Global Therapeutic Nuclear Medicines Market Size Growth Rate by Type: 2020 VS 2026 1.5.2 Radium-223 1.5.3 Lutetium-177 1.5.4 Iodine-131 1.5.5 Other 1.6 Market by Application 1.6.1 Global Therapeutic Nuclear Medicines Market Share by Application: 2021-2026 1.6.2 Thyroid 1.6.3 Bone Metastasis 1.6.4 Lymphoma 1.6.5 Other 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Therapeutic Nuclear Medicines Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter's Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Therapeutic Nuclear Medicines Market Players Profiles 3.1 Bayer 3.1.1 Bayer Company Profile 3.1.2 Bayer Therapeutic Nuclear Medicines Product Specification 3.1.3 Bayer Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.2 Lantheus 3.2.1 Lantheus Company Profile 3.2.2 Lantheus Therapeutic Nuclear Medicines Product Specification 3.2.3 Lantheus Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.3 Dongcheng 3.3.1 Dongcheng Company Profile 3.3.2 Dongcheng Therapeutic Nuclear Medicines Product Specification 3.3.3 Dongcheng Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.4 Novartis AG 3.4.1 Novartis AG Company Profile 3.4.2 Novartis AG Therapeutic Nuclear Medicines Product Specification 3.4.3 Novartis AG Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.5 Jubilant DraxImage 3.5.1 Jubilant DraxImage Company Profile 3.5.2 Jubilant DraxImage Therapeutic Nuclear Medicines Product Specification 3.5.3 Jubilant DraxImage Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.6 China Isotope & Radiation 3.6.1 China Isotope & Radiation Company Profile 3.6.2 China Isotope & Radiation Therapeutic Nuclear Medicines Product Specification 3.6.3 China Isotope & Radiation Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.7 Progenics Pharmaceuticals 3.7.1 Progenics Pharmaceuticals Company Profile 3.7.2 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Product Specification 3.7.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.8 Curium Pharmaceuticals 3.8.1 Curium Pharmaceuticals Company Profile 3.8.2 Curium Pharmaceuticals Therapeutic Nuclear Medicines Product Specification 3.8.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.9 Q BioMed 3.9.1 Q BioMed Company Profile 3.9.2 Q BioMed Therapeutic Nuclear Medicines Product Specification 3.9.3 Q BioMed Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.10 Spectrum Pharmaceuticals 3.10.1 Spectrum Pharmaceuticals Company Profile 3.10.2 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Product Specification 3.10.3 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 3.11 International Isotopes 3.11.1 International Isotopes Company Profile 3.11.2 International Isotopes Therapeutic Nuclear Medicines Product Specification 3.11.3 International Isotopes Therapeutic Nuclear Medicines Production Capacity, Revenue, Price and Gross Margin (2015-2020) 4 Global Therapeutic Nuclear Medicines Market Competition by Market Players 4.1 Global Therapeutic Nuclear Medicines Production Capacity Market Share by Market Players (2015-2020) 4.2 Global Therapeutic Nuclear Medicines Revenue Market Share by Market Players (2015-2020) 4.3 Global Therapeutic Nuclear Medicines Average Price by Market Players (2015-2020) 5 Global Therapeutic Nuclear Medicines Production by Regions (2015-2020) 5.1 North America 5.1.1 North America Therapeutic Nuclear Medicines Market Size (2015-2020) 5.1.2 Therapeutic Nuclear Medicines Key Players in North America (2015-2020) 5.1.3 North America Therapeutic Nuclear Medicines Market Size by Type (2015-2020) 5.1.4 North America Therapeutic Nuclear Medicines Market Size by Application (2015-2020) 5.2 East Asia 5.2.1 East Asia Therapeutic Nuclear Medicines Market Size (2015-2020) 5.2.2 Therapeutic Nuclear Medicines Key Players in East Asia (2015-2020) 5.2.3 East Asia Therapeutic Nuclear Medicines Market Size by Type (2015-2020) 5.2.4 East Asia Therapeutic Nuclear Medicines Market Size by Application (2015-2020) 5.3 Europe 5.3.1 Europe Therapeutic Nuclear Medicines Market Size (2015-2020) 5.3.2 Therapeutic Nuclear Medicines Key Players in Europe (2015-2020) 5.3.3 Europe Therapeutic Nuclear Medicines Market Size by Type (2015-2020) 5.3.4 Europe Therapeutic Nuclear Medicines Market Size by Application (2015-2020) 5.4 South Asia 5.4.1 South Asia Therapeutic Nuclear Medicines Market Size (2015-2020) 5.4.2 Therapeutic Nuclear Medicines Key Players in South Asia (2015-2020) 5.4.3 South Asia Therapeutic Nuclear Medicines Market Size by Type (2015-2020) 5.4.4 South Asia Therapeutic Nuclear Medicines Market Size by Application (2015-2020) 5.5 Southeast Asia 5.5.1 Southeast Asia Therapeutic Nuclear Medicines Market Size (2015-2020) 5.5.2 Therapeutic Nuclear Medicines Key Players in Southeast Asia (2015-2020) 5.5.3 Southeast Asia Therapeutic Nuclear Medicines Market Size by Type (2015-2020) 5.5.4 Southeast Asia Therapeutic Nuclear Medicines Market Size by Application (2015-2020) 5.6 Middle East 5.6.1 Middle East Therapeutic Nuclear Medicines Market Size (2015-2020) 5.6.2 Therapeutic Nuclear Medicines Key Players in Middle East (2015-2020) 5.6.3 Middle East Therapeutic Nuclear Medicines Market Size by Type (2015-2020) 5.6.4 Middle East Therapeutic Nuclear Medicines Market Size by Application (2015-2020) 5.7 Africa 5.7.1 Africa Therapeutic Nuclear Medicines Market Size (2015-2020) 5.7.2 Therapeutic Nuclear Medicines Key Players in Africa (2015-2020) 5.7.3 Africa Therapeutic Nuclear Medicines Market Size by Type (2015-2020) 5.7.4 Africa Therapeutic Nuclear Medicines Market Size by Application (2015-2020) 5.8 Oceania 5.8.1 Oceania Therapeutic Nuclear Medicines Market Size (2015-2020) 5.8.2 Therapeutic Nuclear Medicines Key Players in Oceania (2015-2020) 5.8.3 Oceania Therapeutic Nuclear Medicines Market Size by Type (2015-2020) 5.8.4 Oceania Therapeutic Nuclear Medicines Market Size by Application (2015-2020) 5.9 South America 5.9.1 South America Therapeutic Nuclear Medicines Market Size (2015-2020) 5.9.2 Therapeutic Nuclear Medicines Key Players in South America (2015-2020) 5.9.3 South America Therapeutic Nuclear Medicines Market Size by Type (2015-2020) 5.9.4 South America Therapeutic Nuclear Medicines Market Size by Application (2015-2020) 5.10 Rest of the World 5.10.1 Rest of the World Therapeutic Nuclear Medicines Market Size (2015-2020) 5.10.2 Therapeutic Nuclear Medicines Key Players in Rest of the World (2015-2020) 5.10.3 Rest of the World Therapeutic Nuclear Medicines Market Size by Type (2015-2020) 5.10.4 Rest of the World Therapeutic Nuclear Medicines Market Size by Application (2015-2020) 6 Global Therapeutic Nuclear Medicines Consumption by Region (2015-2020) 6.1 North America 6.1.1 North America Therapeutic Nuclear Medicines Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Therapeutic Nuclear Medicines Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Therapeutic Nuclear Medicines Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Therapeutic Nuclear Medicines Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Therapeutic Nuclear Medicines Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Therapeutic Nuclear Medicines Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Therapeutic Nuclear Medicines Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Therapeutic Nuclear Medicines Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Therapeutic Nuclear Medicines Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Therapeutic Nuclear Medicines Consumption by Countries 7 Global Therapeutic Nuclear Medicines Production Forecast by Regions (2021-2026) 7.1 Global Forecasted Production of Therapeutic Nuclear Medicines (2021-2026) 7.2 Global Forecasted Revenue of Therapeutic Nuclear Medicines (2021-2026) 7.3 Global Forecasted Price of Therapeutic Nuclear Medicines (2021-2026) 7.4 Global Forecasted Production of Therapeutic Nuclear Medicines by Region (2021-2026) 7.4.1 North America Therapeutic Nuclear Medicines Production, Revenue Forecast (2021-2026) 7.4.2 East Asia Therapeutic Nuclear Medicines Production, Revenue Forecast (2021-2026) 7.4.3 Europe Therapeutic Nuclear Medicines Production, Revenue Forecast (2021-2026) 7.4.4 South Asia Therapeutic Nuclear Medicines Production, Revenue Forecast (2021-2026) 7.4.5 Southeast Asia Therapeutic Nuclear Medicines Production, Revenue Forecast (2021-2026) 7.4.6 Middle East Therapeutic Nuclear Medicines Production, Revenue Forecast (2021-2026) 7.4.7 Africa Therapeutic Nuclear Medicines Production, Revenue Forecast (2021-2026) 7.4.8 Oceania Therapeutic Nuclear Medicines Production, Revenue Forecast (2021-2026) 7.4.9 South America Therapeutic Nuclear Medicines Production, Revenue Forecast (2021-2026) 7.4.10 Rest of the World Therapeutic Nuclear Medicines Production, Revenue Forecast (2021-2026) 7.5 Forecast by Type and by Application (2021-2026) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026) 7.5.2 Global Forecasted Consumption of Therapeutic Nuclear Medicines by Application (2021-2026) 8 Global Therapeutic Nuclear Medicines Consumption Forecast by Regions (2021-2026) 8.1 North America Forecasted Consumption of Therapeutic Nuclear Medicines by Country 8.2 East Asia Market Forecasted Consumption of Therapeutic Nuclear Medicines by Country 8.3 Europe Market Forecasted Consumption of Therapeutic Nuclear Medicines by Countriy 8.4 South Asia Forecasted Consumption of Therapeutic Nuclear Medicines by Country 8.5 Southeast Asia Forecasted Consumption of Therapeutic Nuclear Medicines by Country 8.6 Middle East Forecasted Consumption of Therapeutic Nuclear Medicines by Country 8.7 Africa Forecasted Consumption of Therapeutic Nuclear Medicines by Country 8.8 Oceania Forecasted Consumption of Therapeutic Nuclear Medicines by Country 8.9 South America Forecasted Consumption of Therapeutic Nuclear Medicines by Country 8.10 Rest of the world Forecasted Consumption of Therapeutic Nuclear Medicines by Country 9 Global Therapeutic Nuclear Medicines Sales by Type (2015-2026) 9.1 Global Therapeutic Nuclear Medicines Historic Market Size by Type (2015-2020) 9.2 Global Therapeutic Nuclear Medicines Forecasted Market Size by Type (2021-2026) 10 Global Therapeutic Nuclear Medicines Consumption by Application (2015-2026) 10.1 Global Therapeutic Nuclear Medicines Historic Market Size by Application (2015-2020) 10.2 Global Therapeutic Nuclear Medicines Forecasted Market Size by Application (2021-2026) 11 Global Therapeutic Nuclear Medicines Manufacturing Cost Analysis 11.1 Therapeutic Nuclear Medicines Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines 12 Global Therapeutic Nuclear Medicines Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Therapeutic Nuclear Medicines Distributors List 12.3 Therapeutic Nuclear Medicines Customers 12.4 Therapeutic Nuclear Medicines Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Price : US$ 3,500 | Date : May 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 115 |
Price : US$ 3,500 | Date : Apr 2024 |
Category : Manufacturing and Construction | Pages : 116 |
Price : US$ 3,500 | Date : Mar 2024 |
Category : Medical Devices | Pages : 233 |
Price : US$ 3,500 | Date : Mar 2024 |
Category : Energy, Mining and Utilities | Pages : 233 |
Price : US$ 2,450 | Date : Feb 2024 |
Category : Healthcare and Pharmaceuticals | Pages : 260 |
We will be happy to help you find what you need. Please call us or write to us: